Coronary Artery Disease (CAD) in Patients HIV-infected

NCT04579146 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2022-01-19

No results posted yet for this study

Summary

HIV-infected patients with intermediate-high risk have a high prevalence of CAD and a substantial proportion of obstructive CAD. Degree of stenosis is associated with immunoactivation (lymphocyte and monocyte) and microbial translocation

Conditions

  • HIV Infections

Interventions

OTHER

coronary computed tomographic angiographic (CCTA)

x-ray examination with contrast by a 64-slice CT coronary angiography.

Sponsors & Collaborators

  • Hôpital Européen Marseille

    lead OTHER

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-07
Primary Completion
2022-10-31
Completion
2023-10-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04579146 on ClinicalTrials.gov